Remdesivir, which is administered intravenously in hospital, is the first drug to show improvement in COVID-19 patients in formal clinical trials and is at the forefront of the battle against COVID-19, which has no approved treatment or vaccine.
from Hindustan Times - topnews https://ift.tt/3gL7mUG
via IFTTT
No comments:
Post a Comment